Company · CIK 0001692830
Satsuma Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ASatsuma Pharmaceuticals, Inc.0001567619-23-006340 · 83.0 KBSEC(opens sec.gov)
- SC 13D/ASatsuma Pharmaceuticals, Inc.0001104659-23-070413 · 83.0 KBSEC(opens sec.gov)
- SC 13D/ASatsuma Pharmaceuticals, Inc.0001193125-23-163095 · 89.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-163082 · 337.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-148162 · 183.1 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-23-021208 · 7.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-134402 · 147.1 KBSEC(opens sec.gov)
- SC 13D/ASatsuma Pharmaceuticals, Inc.0001072613-23-000316 · 129.1 KBSEC(opens sec.gov)
- 10-K/ASatsuma Pharmaceuticals, Inc.0000950170-23-015782 · 3.4 MBSEC(opens sec.gov)
- SC 13D/ASatsuma Pharmaceuticals, Inc.0001104659-23-046734 · 101.5 KBSEC(opens sec.gov)
Insiders
- ALBRECHT DETLEFChief Medical Officer
- BONDERMAN DAVID10% Owner
- Commodore Capital LP10% Owner
- COULTER JAMES G10% Owner
- Hadley Harbor Master Investors (Cayman) II L.P.10% Owner
- Harsch MutyaDirector
- KING THOMAS BRAXTONDirector
- Kolchinsky PeterFormer 10% Owner
- Kollins John ADirector, President and CEO
- Leonard Braden Michael10% Owner
Tickers
No tickers on record.
Addresses
business
4819 EMPEROR BOULEVARD SUITE 340
DURHAM, NC, 27703
mailing
4819 EMPEROR BOULEVARD SUITE 340
DURHAM, NC, 27703
Same industry